Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly
Preprint
- 1 March 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Heterogeneity in vaccine response, particularly in vulnerable populations like the elderly, represents a significant public health challenge. We conducted an in-depth examination of immune cell profiles before and after SARS-CoV-2 vaccination utilizing mass cytometry in a cohort of healthy Norwegian seniors (65–80 years). We have demonstrated that higher pre-vaccination frequencies of CD27+IgD− class-switched memory B cells and subsets of CD27−CD24+CD38+ transitional B cells were associated with a robust vaccine response. Post-vaccination, high responders exhibited increased frequencies of IFN-γ+CD4+ T cells with antigen recall and a concurrent decrease in TH17 cell subset frequencies compared to low responders. The presence of a γδ T cell subset displaying polyfunctional cytokine responses was also associated with better vaccine response in the elderly. This comprehensive analysis sheds light on inherent differences in immune cell frequencies and functions that should offer insights for targeted vaccination strategies in older populations.Keywords
All Related Versions
- Version 1, 2024-03-01, Research Square
- Published version: npj Vaccines, 9 (1), 1.
This publication has 33 references indexed in Scilit:
- Global impact of the first year of COVID-19 vaccination: a mathematical modelling studyThe Lancet Infectious Diseases, 2022
- Infection fatality rate of COVID-19 in community-dwelling elderly populationsEuropean Journal of Epidemiology, 2022
- Human influenza virus challenge identifies cellular correlates of protection for oral vaccinationCell Host & Microbe, 2021
- Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationImmunity, 2021
- Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host DynamicsCell, 2020
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialThe Lancet, 2020
- Emerging role of γδ T cells in vaccine‐mediated protection from infectious diseasesClinical & Translational Immunology, 2019
- Mass Cytometry: Single Cells, Many FeaturesCell, 2016
- Molecular and cellular basis of immunosenescenceMechanisms of Ageing and Development, 1998